Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Receivables (2018 - 2025)

Viemed Healthcare's Receivables history spans 8 years, with the latest figure at $25.6 million for Q4 2025.

  • For Q4 2025, Receivables rose 2.71% year-over-year to $25.6 million; the TTM value through Dec 2025 reached $25.6 million, up 2.71%, while the annual FY2025 figure was $25.6 million, 2.71% up from the prior year.
  • Receivables reached $25.6 million in Q4 2025 per VMD's latest filing, down from $27.4 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $27.4 million in Q3 2025 to a low of $12.1 million in Q2 2021.
  • Average Receivables over 5 years is $19.5 million, with a median of $17.9 million recorded in 2023.
  • Peak YoY movement for Receivables: fell 13.99% in 2021, then soared 51.25% in 2024.
  • A 5-year view of Receivables shows it stood at $12.8 million in 2021, then rose by 19.93% to $15.4 million in 2022, then grew by 19.98% to $18.5 million in 2023, then soared by 35.01% to $24.9 million in 2024, then increased by 2.71% to $25.6 million in 2025.
  • Per Business Quant, the three most recent readings for VMD's Receivables are $25.6 million (Q4 2025), $27.4 million (Q3 2025), and $26.5 million (Q2 2025).